Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project)

Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project)

Authors of this article:

Steffen Flindt Nielsen^{1, 2} ;   Camilla Lundgreen Duus^{1, 2} ;   Niels Henrik Buus^{2, 3} ;   Jesper Nørgaard Bech^{1, 2} ;   Frank Holden Mose^{1, 2}